Proteomic Analysis of Amniotic Fluid to Predict Postnatal Renal Function in Fetuses With Renal and Urinary Tract Malformations
Recruiting
N/A
Interventional Study
Kidney Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Female
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 78 (estimated)
- Sponsor
- University Hospital, Toulouse · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this project is to validate a previously established amniotic fluid 98 peptide signature predictive of post-natal outcome in fetuses with congenital anomalies of the kidney and the urinary tract (CAKUT) in a "real" clinical context. It includes the feasibility of collecting, transporting and analyzing the amniotic fluid peptidome from clinical centers all over France and of providing th…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All fetuses with bilateral renal development anomalies with structural changes in the parenchyma, with or without associated urinary tract anomalies;
* Signed informed consent of the mother
* Non-opposition of the father.
Exclusion Criteria:
* Unilateral abnormality of renal…
Contacts